Researchers from the University of Queensland developed a treatment in helping patients suffering from sepsis and acute respiratory distress syndrome.
The recent breakthrough shows promise in improving recovery times for heart attacks, extensive burns or major traumas. This developed protein called EphA4-Fc may be able to repair and prevent damage to cell lining blood vessels damaged by inflammation.
UQ’s research commercialisation company, UniQuest partnered with biotech firm CSL Behring to further develop the treatment.